CURRICULUM VITAE
`
`GERALD WALTER CHODAK, MD
`
`
`
`June 2016
`
`
`
`
`
`
`
`CURRENT:
`
`Editor-in-Chief, www.ProstateVideos.com
`
`Medscape- Controversies in Urology Video Series
`Author- WINNING THE BATTLE AGAINST PROSTATE CANCER,
`Second edition
`
`
`PERSONAL DATA:
`
`Birth: 13 March 1947, New York, NY
`
`EDUCATION:
`
`1965-1969- University of Rochester, B.A. Chemistry
`
`1969-1971- State University of New York at Buffalo, M.A. Chemistry
`
`1971-1975- State University of New York at Buffalo, M.D.
`
`TRAINING
`
`Internship:
`Assistant Resident in Surgery, Buffalo General Hospital and Clinical Lecturer in
`Surgery, SUNY at Buffalo School of Medicine, Buffalo, NY, July 1975 - 1976.
`
`Residency:
`Assistant Resident in Surgery, UCLA Medical Center and Clinical Lecturer in
`Surgery, UCLA School of Medicine, July 1976 - June 1977.
`
`Assistant Resident in Surgery/Urology, Peter Bent Brigham Hospital Medical
`Center, Boston, MA, July 1977 - June 1979.
`
`
`
`JANSSEN EXHIBIT 2043
`Amerigen v. Janssen IPR2016-00286
`
`
`
`GERALD WALTER CHODAK, MD
`
`
`
`June 2016
`
`
`
`
`
`
`
`CURRENT:
`
`Editor-in-Chief, www.ProstateVideos.com
`
`Medscape- Controversies in Urology Video Series
`Author- WINNING THE BATTLE AGAINST PROSTATE CANCER,
`Second edition
`
`
`PERSONAL DATA:
`
`Birth: 13 March 1947, New York, NY
`
`EDUCATION:
`
`1965-1969- University of Rochester, B.A. Chemistry
`
`1969-1971- State University of New York at Buffalo, M.A. Chemistry
`
`1971-1975- State University of New York at Buffalo, M.D.
`
`TRAINING
`
`Internship:
`Assistant Resident in Surgery, Buffalo General Hospital and Clinical Lecturer in
`Surgery, SUNY at Buffalo School of Medicine, Buffalo, NY, July 1975 - 1976.
`
`Residency:
`Assistant Resident in Surgery, UCLA Medical Center and Clinical Lecturer in
`Surgery, UCLA School of Medicine, July 1976 - June 1977.
`
`Assistant Resident in Surgery/Urology, Peter Bent Brigham Hospital Medical
`Center, Boston, MA, July 1977 - June 1979.
`
`
`
`JANSSEN EXHIBIT 2043
`Amerigen v. Janssen IPR2016-00286
`
`
`
`
`
`
`Research Associate in Surgery, Children's Hospital Medical Center, Boston, MA,
`July 1978 - June 1979.
`
`Senior and Chief Resident in Urology, The University of Chicago, July 1979 - June
`1981.
`
`Fellowships:
`Research Associate, Section of Urology, The University of Chicago, July 1981 -
`June 1982.
`Research Associate, Department of Surgery, Children's Hospital and Medical
`Center, Boston, MA, July 1981 - June 1982.
`
`FACULTY APPOINTMENTS:
`
`Professor of Urology, The University of Chicago, 1990-1999
`Associate Professor of Urology, The University of Chicago, 1985 - 1990
`Assistant Professor of Urology, The University of Chicago, 1982 - 1985
`
`LICENSURE AND BOARD CERTIFICATION:
`
`License - State of Illinois
`Board of Urology - 1984
`
`HONORS AND AWARDS:
`
`
`NIH National Cancer Scientist Trainee, Fellowship for graduate work in
`Immunochemistry, September 1969 - September 1973
`
`Third Prize, Chicago Urological Society Pyelogram Contest,
`March 1980
`
`First Prize, American Urological Association, Walter A. Kerr Essay Contest on
`Methods of Cost Control in Urologic Care, May 1980
`
`
`
`
`
`
`
`
`
`
`First Prize, American Urological Association, Grayson Carroll Contest for Clinical
`Research, May 1980
`
`American Urological Association Scholar, July 1981 - June 1983
`
`American Cancer Society Junior Faculty Clinical Scholar, 1982 - 1985
`
`The University of Chicago Gould Foundation Faculty Scholar, 1983 - 1984
`
`Chicago Community Trust Award, 1983 - 1984
`
`SOCIETIES:
`
`American Urological Association
`
`COMMITTEES:
`
`American Cancer Society Early Detection Committee, 2008- 2012
`PLCO Data and Safety Monitoring Committee, NCI 2005-2012
`Early Detection and Prevention Committee, The American Cancer Society,
`Chicago Unit, 1983 - 1986
`Physicians Professional Education Committee, the American Cancer Society,
`Chicago Unit, 1983 - 1984
`
`
`PUBLICATIONS:
`
`Books
`
`WINNING THE BATTLE AGAINST PROSTATE CANCER, Second Edition
`Published by Demos Health, September 2013
`
`WINNING THE BATTLE AGAINST PROSTATE CANCER
`Published by Demos Health, September 2010
`
`
`
`
`
`
`
`
`PROSTATE CANCER: REDUCING YOUR RISKS
`Published by Vook, 2010
`
`Original Articles
`
`1. Bailey D, Montgomery F, Chodak GW and Saunders W. Mechanisms of
`elimination reactions XVII. The relationship between stereochemistry and
`trans:CIS rations in eliminations from open chain quaternary ammonium salts.
`JACS 92:6911- 16913, 1970.
`
`2. Chodak GW and Plaut ME. Use of systemic antibiotics for prophylaxis in
`surgery. Arch Surg 112:326-334, 1977.
`
`3. Chodak GW and Plaut ME. Wound infections and systemic antibiotic
`prophylaxis in gynecologic surgery: Ob/Gyn 51:123-127, 1978.
`
`4. Chodak GW and Passaro E. Acid ingestion: Guidelines for management, a
`review and case report. JAMA 239:225-226, 1978.
`
`5. Chodak GW and Plaut ME. Systemic antibiotics for prophylaxis in urologic
`surgery. J Urol 121:695-699, 1979.
`
`6. Chodak GW, Haudenschild C, Gittes RF and Folkman J. Angiogenesis activity
`as a marker of neoplastic and pre-neoplastic lesions of the human bladder. Ann
`Surg 192:762-771, 1980.
`
`7. Chodak GW, Summerhayes I and Folkman J. Angiogenesis assay of benign
`and malignant mammalian urothelium. Surg Forum 31:587-589, 1980.
`
`8. Chodak GW, Rangel D and Passaro E. Colonic diverticulitis in the young:
`Challenge to conventional therapy. Amer J of Surg 141:699-702, 1981.
`
`9. Chodak GW, Scheiner C and Zetter BR. Urine from patients with transitional
`cell carcinoma stimulates migrations of capillary endothelial cells. NEJM
`305:869-874, 1981.
`
`
`
`
`
`
`
`
`10. Chodak GW. Evaluation of the use of prophylactic antibiotics in urologic
`surgery. Infection Control and Urological Care 5:14-16, 1981.
`
`11. Chodak GW, Straus FH II and Schoenberg HW. Simultaneous occurrence of
`transitional, squamous and adenocarcinoma of the bladder after 15 years of
`cyclophosphamide ingestion. J Urol 125:424-426, 1981.
`
`12. Chodak G, Huffman J, Schoenberg HW, and Lyon ES. Technique for
`replacing indwelling double-J ureteral stents. Urol 14:544-545, 1982.
`
`13. Chodak GW, Gill WB, Wald VC and Spargo B. Diagnosis of renal
`parenchymal diseases by a modified open kidney biopsy technique. Kid Intern
`24:804806, 1983.
`
`14. Chodak GW. Case Studies in Oncology-Disseminated Bladder Cancer.
`Continuing Professional Education, January, 1983.
`
`15. Guillery EN and Chodak GW. A technique for continuous infusion into the
`mouse bladder. Invest Urol 131:10051007, 1984.
`
`16. Chodak GW and Schoenberg HW. Early detection of prostate cancer by
`routine screening. JAMA 252:32613264, 1984.
`
`17. Chodak GW, Bibbo M, Straus FH II and Wied GL. Transrectal aspiration
`biopsy vs. transperineal core biopsy for the diagnosis of carcinoma of the prostate.
`J Urol 132:480482, 1984.
`
`18. Chodak GW and Summerhayes I. Detection of angiogenesis activity in
`malignant bladder tissue and cells. Invest Urol 132:10321035, 1984.
`
`19. Chodak GW. Tumor Angiogenesis: Importance in Tumor Detection and
`Growth. Urologic Oncology 1-13, 1984.
`
`
`
`
`
`
`
`
`20. Chodak GW. Endocrine Treatment of Prostatic Cancer (letter). Urology 23
`(2):224-225, February, 1984.
`
`21. Chodak GW, Klagsbrun M and Shing YW. Partial characterization of a cell
`motility factor from human urine. Cancer Research 45:690694, 1985.
`
`22. Chodak GW, Steinberg GD, Bibbo M, Wied G, Straus FS II, Vogelzang NJ
`and Schoenberg HW. The role of transrectal aspiration biopsy in the diagnosis of
`prostatic cancer. J Urol 135:299302, 1986.
`
`23. Chodak GW, Wald V, Parmer E, Watanabe H, Ohe H, and Saitoh M.
`Comparison of digital examination and transrectal ultrasonography for diagnosis of
`prostatic cancer. J Urol 135:951954, 1986.
`
`24. Chodak GW, Shing Y, Borge M, Judge SM and Klagsbrun M. Presence of
`heparin binding growth factor in mouse bladder tumors and urine from mice with
`bladder cancer. Cancer Research 46:55075510, l986.
`
`25. Vogelzang NJ, Arnold JL, Chodak GW, and Schoenberg HW. Androgen and
`germ cell testicular cancers. JAMA 255:906, 1986.
`
`26. Chodak GW. Prostatitis, Epididymitis, and Balanoposthitis. Current Therapy
`in Infectious Disease 248-251, 1986.
`
`27. Vogelzang NJ, Ruane M, Ratain MJ, Dhowlatshahi K and Chodak GW. A
`programmable and implantable pumping system for systemic chemotherapy: A
`performance analysis in 52 patients. J Clin Onc 5:1968-1976, 1987.
`
`28. Chodak GW. Questions and Answers-Diagnostic and Therapeutic Assessment
`(DATTA). JAMA 257 (9):1238-1240, March, 1987.
`
`29. Brawer MK, Chodak GW. Ultrasound Offers Assist in Diagnosing Prostate
`Cancer. Diagnostic Imaging 154-157, October, 1987.
`
`
`
`
`
`
`
`
`30. Chodak GW, Hospelhorn V, Judge SM, Mayforth R, Kepper H and Sasse J.
`Increased levels of fibroblast growth factor-like activity in urine from patients with
`bladder or kidney cancer. Cancer Research 48:2083-2088, 1988.
`
`31. Chodak GW, Keller P, Schoenberg H. Routine Screening for Prostate Cancer
`Using the Digital Rectal Examination. Prog Clin Biol Res 269:87-98, 1988.
`
`32. Chodak GW, Smith FL, Bibbo M, Schoenberg HW. The Role of Transrectal
`Aspiration Biopsy in the Diagnosis of Carcinoma of the Prostate. Prog Clin Biol
`Res 269:11-20, 1988.
`
`33. Smith FL, Bibbo M, Schoenberg HW and Chodak GW. Transrectal aspiration
`biopsy of the prostate: The importance of atypia. J Urol 140:766-768, 1988.
`
`34. Chodak, GW. Transrectal Ultrasonography: Is it Ready for Routine Use?
`JAMA 259(18):2744-2745, May, 1988.
`
`35. Gruber B, Moran WJ, Pearle MS, Strauss FF and Chodak GW. Prostate
`cancer presenting as facial paralysis. Otolaryngology -Head and Neck Surgery.
`
`36. Chodak GW, Keller, P and Schoenberg HW. Assessment of screening for
`prostate cancer using the digital rectal examination. J Urol 141:1136-1138, 1989.
`
`37. Chodak GW and Schoenberg HW. Progress and problems in screening for
`carcinoma of the prostate. World J Surg 13:60-64, 1989.
`
`38.Chodak GW. Luteinizing hormone-releasing hormone (LHRH) agonists for
`treatment of advanced prostatic carcinoma. Urol 33:42-44, 1989.
`
`39.Chodak GW. Early detection and screening for prostatic cancer. Urol 37:10-
`12, 1989.
`
`40.Chodak GW. Intravesical interferon treatment of superficial bladder cancer.
`Urol 37:84-86, 1989.
`
`
`
`
`
`
`
`
`41. Chodak GW. Early detection of prostate cancer. Hormone Research 32:35-37,
`1989.
`
`42. Chang C, Chodak GW, Sarac E, Takeda H and Liao S. Prostate androgen
`receptor: Immunohistological localization and mRNA characterization. J Steroid
`Biochem, pp 1-3, 1989.
`
`43. Chodak GW. Screening for Prostate Cancer-Role of Ultrasonography.
`Urologic Clinics of North America 16:657-661, November, 1989.
`
`44. Chodak, GW. Questions and Answers-Screening for Prostate Cancer After
`Anal Closure. JAMA 262(17):2446, November, 1989.
`
`45. Chodak GW, Neumann J, Blix G, Sutton H and Farah R. Effect of external
`beam radiation therapy on serum prostatic specific antigen. Urol 34:288-294,
`1990.
`
`46. Gerber GS and Chodak GW. Prostate specific antigen for assessing response
`to ketaconazole and prednisone in patients with hormone refractory metastatic
`prostate cancer. J Urol 144:1177-1179, 1990.
`
`47. Takeda H, Chodak GW and Chang C. Immunohistochemical localization of
`androgen receptors in rodent male sexual organs. J Endo 126:17-25, 1990.
`
`48. Chodak GW. The diagnosis and management of localized prostate cancer.
`Genitourinary Group Monograph 7: Prostate Cancer and Testicular Cancer, pp. 1-
`6, Wiley-Liss, Inc. 1990.
`
`49. Gerber GS and Chodak GW. Cellular diagnosis methods for prostate cancer:
`Cytology vs. core biopsy. Problems in Urology, David F. Paulson, MD (ed.) J.B.
`Lippincott, Philadelphia, 1990.
`
`50. Gerber GS and Chodak GW. Prostate biopsy: Convention and innovation
`under scrutiny. Contemporary Urology, p.24-28, 1990.
`
`
`
`
`
`
`
`
`51. Chodak GW. Screening for prostate cancer. Infections in Urology, p.97-100,
`1990.
`
`52. Chodak GW. Therapy options for carcinoma in situ of the bladder. Biotherapy
`& Cancer 3:3, l990.
`
`53. Glashan RW, et al. A randomized controlled study of intravesical a-2B-
`interferon in carcinoma in situ of the bladder. J Urol 144:658-661, 1990.
`
`54. Gerber GS and Chodak GW. Digital rectal examination in the early detection
`of prostate cancer. Urologic Clinics of North America 17:739-744, November
`1990.
`
`55. Soloway MS, Chodak GW, Vogelzang NJ, Block NL, Schellhammer PF,
`Smith JA, Jr, Scott M, Kennealey G and Gau TC. Zoladex versus orchiectomy in
`the treatment of advanced prostate cancer: A randomized trial. Urol 37:46-51,
`1991
`
`56. Silver RI, Straus FH, Vogelzang NJ, Kellman H and Chodak GW. Response to
`orchiectomy following Zoladex therapy for metastatic prostate carcinoma. Urol
`37:17-21, 1991.
`
`57. Chodak GW, Vogelzang NJ, Caplan RJ, Soloway M and Smith JA.
`Independent prognostic factors in patients with metastatic (stage D2) prostate
`cancer. JAMA 265:618-621, 1991.
`
`58. Chodak GW. Limitations of screening for prostate cancer. Diagnostic
`Oncology 1:105-110, 1991.
`
`59. Gerber GS and Chodak GW. Routine screening for cancer of the prostate. J
`Natl Cancer Inst 83:329-335, 1991.
`
`60. Gerber GS and Chodak GW. Assessment of value of routine bone scans in
`patients with newly diagnosed prostate cancer. Urol 37/5:418-422, 1991.
`
`
`
`
`
`
`
`
`61. Gerber GW and Chodak GW. Detection of clinically occult prostate cancer in
`men with benign prostatic hyperplasia. Problems in Urology 5/3:380-385, July-
`September, 1991.
`
`62. Gerber GS and Chodak GW. Comparison of fine needle aspiration and
`ultrasound guided core biopsy of palpable prostatic lesions. J of Endourology
`5/4:333-336, 1991.
`
`63. Chodak GW. A second opinion on transrectal ultrasound. Primary Care and
`Cancer ll/6:39, 1991.
`
`64. Takeda H, Nakamoto T, Kokontis J, Chodak GW and Chang C.
`Autoregulation of androgen receptor expression in rodent prostate:
`Immunohistochemical and in situ hybridization analysis. Biochemical and
`Biophysical Research Communications 177,1:488-496, 1991.
`
`65. Chodak GW and Gerber G. Letter to editor. Response to routine screening for
`cancer of the prostate written by Crawford ED. Journal of the National Cancer
`Institute 18/83:1346-1347, September 1991.
`
`66. Chodak GW. Treatment of early prostatic cancer. Acta Oncologica 30/2:243,
`1991.
`
`67. Chodak GW. Prostate cancer: To screen or not to screen. Acta Oncologica
`30/2:285, 1991.
`
`68. Farah R, Chodak GW, Vogelzang NJ, Awan AM, Quiet CA,Moormeier J,
`Schoenberg H and Weichselbaum RR. Curative radiotherapy following
`chemotherapy for invasive bladder carcinoma (A preliminary report). Int J
`Radiation Oncology Biol Phys 20/3:413-417, 1991.
`
`69. Doose DR, Minn FL, Stellar S, Nayak RK. Effects of meals and meal
`composition on the bioavailability of fenretinide. J Clin Pharmacol 32:1089-1095,
`1992.
`
`
`
`
`
`
`
`
`70. Thompson IM, Chodak GW. The Natural History of Adenocarcinoma of the
`Prostate. Jr Cell Biochem 16H(Suppl):20-25 1992.
`
`71. Nakamoto T, Chang C, Li A and Chodak GW. Basic fibroblast growth factor
`in human prostate cancer cells. Cancer Research 52, 571-577, February 1992.
`
`72. Crawford ED, Schutz MJ, Clejan S, Drago J, Resnick MI, Chodak GW,
`Gomella LG, Austenfeld M, Stone NN, Miles BJ and
`Thompson R. The effect of digital rectal examination on prostate-specific antigen
`levels. JAMA 267/16:2227-2228, April, 1992.
`
`73.Chodak GW, Puy LA, Kranc DM, Takeda H. Johnson K, Chang C. (1992)
`Nuclear Localization of Androgen Receptor in Heterogenous Samples of Normal,
`Hyperplastic and Neoplastic Human Prostate. Journal of Urology 147:798-803.
`
`74. Gerber GS, Chodak GW. Staging Bone Scintigraphy in Patients with Newly
`Diagnosed Prostate Cancer. MedicalCare International May/June 1992.
`
`75. Resnick MI, Andriole GL, Brawer MK, Chodak GW, Thompson IM. What Is
`Our Objective When We Screen For Prostate Cancer? Contemporary Urology
`4/9:88-107, September 1992.
`
`76. Gerber GS., Chodak GW. Laparoscopic Pelvic Lymphadenectomy. Infections
`in Urology Vol 5, No. 5:142-149 September/October 1992.
`
`77. Gerber GS, Goldberg R, Chodak GW. Local Staging of Prostate Cancer by
`Tumor Volume, Prostate-Specific Antigen, and Transrectal Ultrasound. Urology
`40:311-316, October, 1992.
`
`
`78. Catalona WJ, Denis LJ, Schroder FH, Kirk D, Chodak GW, Parkes C, Wald N.
`Screening for Prostatic Diseases. Prospectives (Special Issue):1-8 November/1992.
`
`79. Chodak GW, Babaian RJ, Williams RD, Diagnosis and Management of
`Lymph Node Metastases from Prostate Cancer. Contemporary Surgery 41:73-88
`November 1992 (Symposium).
`
`
`
`
`
`
`
`
`80. Rukstalis DB, Chodak GW. Laparoscopic Retroperitoneal Lymph Node
`Dissection in a Patient With Stage 1 Testicular Carcinoma. J Urol Vol. 148, 1907-
`1910, December 1992
`
`81. Chodak GW. Screening for Prostate Cancer. Eur Urol 24(Suppl2):3-5, 1993.
`
`82. Chodak GW, Trachtenberg J., Denis LJ. Workshop Summary: Screening
`Policies and Procedures. Eur Urol 24(suppl 2):22-23, 1993.
`
`83. Vogelzang NJ, Olson D, Chodak GW. Blindness Secondary to Prostate
`Cancer. Support Care Cancer 1:156-158, 1993.
`
`84. Chang C, Saltzman A, Lee HJ, Uemura H, Su C, Chodak G, Nakamoto T,
`LeBeau MM, Espinosa R, Davis E, Lemons RS, Sivak L, Shih C. Genomic
`Structure Chromosomal Localization and Expression of an Androgen Inducible
`TR3 Orphan Receptor: A Member of the Steroid Receptor Superfamily. Endocrine
`Journal 1:541-549, 1993.
`
`
`85. Gerber GS, Thompson IM, Thisted R, Chodak GW. Disease-Specific Survival
`Following Routine Prostate Cancer Screening by Digital Rectal Examination.
`JAMA 269(1):61-64, January, 1993.
`
`86. Gerber GS, Rukstalis DB, Levine LA, Chodak GW. Current and Future Roles
`of Laparoscopic Surgery in Urology. Urology 41(1 Suppl):5-9, January, 1993.
`
`87. Kavoussi L, Sosa E, Chandhoke P, Chodak GW, Clayman R, Hadley H,
`Loughlin K, Ruckle H, Rukstalis D, Schuessler W, Segura J, Vancaille T, Winfield
`H. Complications of Laparoscopic Pelvic Lymph Node Dissection. J of Urol. Vol
`149, 322-325, February 1993.
`
`88. Chodak GW. Screening and Early Detection of Prostate Cancer. Cancer 71(3
`Suppl):981-983, February, 1993.
`
`
`
`
`
`
`
`
`
`89. Gerber GS, Rukstalis DB, Chodak GW. The Role of Laparoscopic
`Lymphadenectomy in Staging and Treatment of Urological Tumors. Ann Med
`25(2):127-129, April, 1993.
`
`90. Vogelzang NJ, Moormeier JA, Awan AM, Weichselbaum RR, Farah R,
`Stratus FH, Schoenberg HW, Chodak GW. Methotrexate, Vinblastine,
`Doxorubicin and Cisplatin Followed by Radiotherapy or Surgery for Muscle
`Invasive Bladder Cancer: the University of Chicago Experience. Jr of Urology
`149(4):753-757, April, 1993.
`
`91. Chodak, GW. Screening for Prostate Cancer in 1993: Is it Appropriate or Not?
`Seminars in Urology Vol. XI, No. 2, 47-49, May 1993.
`
`92. Gerber, GS, Chodak, GW. Pros and Cons of Watchful Waiting for Apparently
`Localized Prostate Cancer. Problems in Urology: Therapeutic Strategies in
`Prostate Cancer, Vol. 7, No. 2, 254-259, June 1993.
`
`93. Gerber, GS, Chodak, GW. Early Diagnosis of Prostate Cancer. Important
`Advances in Oncology 1993, 93-101.
`
`94. Chodak, GW. Questioning the Value of Screening for Prostate Cancer in
`Asymptomatic Men. Urology Vol. 42, No. 2, 116-118, August 1993.
`
`95. Gerber, GS, Chodak, GW. Value of Prostate Cancer Screening.
`European Urology Vol 24, No. 224:161-165. August 1993.
`
`96. Chodak GW. Cryosurgery of the Prostate Revisited (editorial). Cancer
`72(4):1145-1146, August, 1993.
`
`97. Rukstalis DB, Gerber GS, Chodak GW. The application of Laparoscopy to
`Retroperitoneal Surgery in Urology. Arch Esp Urol 46(7): 577-580, September,
`1993.
`
`
`
`
`
`
`
`
`98. Ilkay, AK, Chodak, GW, Vogelzang, NJ, Gerber, GS. Buschke-Lowenstein
`Tumor: Therapeutic Options Including Systemic Chemotherapy. Urology Vol. 42,
`No. 5, November 1993.
`
`99. Gerber GS, Thisted R, Chodak GW, Thompson IM. Disease-specific survival
`following routine prostate cancer screening by digital rectal examination:
`corrected patient classification (letter, comment). JAMA 270(20): 2437,
`November, 1993.
`
`100. Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adodlfsson J, Jones
`GW, Chisholm GD, Moskovitz B, Livne PM, Warner J. Results of Conservative
`Management of Clinically Localized Prostate Cancer. NEJM 1994; Vol. 330,
`No.4:242-248.
`
`101. Chodak GW. Treatment of Early Stage Prostate Cancer: Conservation
`Management- -Delayed Therapy. Important Adv Oncol 241-244, 1994.
`
`102. Chodak, GW. The Role of Laparoscopic Lymphadenectomy in the
`Management of Carcinoma of the Prostate. Urology International
`Vol. 1, No. 1:6, January 1994.
`
`103. Igawa M, Rukstalis DB, Tanabe T, Chodak GW. High Levels of nm23
`Expression are related to cell proliferation in human prostate cancer. Cancer
`Research 54:1313-1318, March, 1994.
`
`104. Rukstalis DB, Gerber GS, Vogelzang NJ, Haraf DJ, Straus FH, Chodak GW.
`Laparoscopic Pelvic Lymph Node Dissection: A Review of 103 Consecutive
`Cases. J of Urology 151(3):670-674, March, 1994.
`
`105. Chodak GW. Prostate Cancer: making decisions in 1994. Urology Times
`22(4):2-3, April, 1994.
`
`106. Myers RE, Wolf TA, Balshem AM, Ross EA, Chodak GW. Receptivity of
`African-American Men to Prostate Cancer Screening. Urology Vol. 43, No. 4:480-
`487, April 1994.
`
`
`
`
`
`
`
`
`107. Chodak GW. Urology. JAMA 271(21): 1717-1718, June 1994.
`
`108. Igawa M, Tanabe T, Chodak GW, Rukstalis DB. N-(4-Hydrozphenyl)
`retinamide Induces Cell Cycle Specific Growth Inhibition in PC3 cells. Prostate
`24(6): 299-305, June, 1994.
`
`109. Chodak GW. The relative benefit of radical prostatectomy or radiation
`therapy over watchful waiting for treating men older than 70 years with localized
`prostate cancer is extremely small. JAMA Vol. 271, No. 21:1717-1718, June 1994.
`
`110. Bales GT, Fellner SK, Chodak GW, Rukstalis DB. Laparoscopic Bilateral
`Nephrectomy for Renin-mediated Hypertension. Urology 43(6): 874-7, June 1994.
`
`111. Chodak GW. Screening for Prostate Cancer. The Debate Continues
`(editorial; comment). JAMA 272(10): 813-814, September, 1994.
`
`112. Chodak GW. The role of conservative management in localized prostate
`cancer. Cancer 74(7): 2178-2181, October, 1994.
`
`113. Moon TD, Brannan W, Stone NN, Ercole C, Crawford ED, Chodak GW,
`Brawer M, Heisey D, Bruskewitz RC. Effect of Age, Educational Status, Ethnicity
`and Geographic Location on Prostate Symptom Scores. J of Urol 152(5): 1498-
`1500, November, 1994.
`
`114. Chodak GW. The Role of Watchful Waiting in the Management of
`Localized Prostate Cancer. J of Urology 152:1766-1768, November, 1994.
`
`115. Bales GT, Chodak GW. Cryosurgery for Stage T3 Prostate Cancer (letter).
`Urology 44(5): 59-90, November, 1994.
`
`116. Haraf DJ, Rubin SJ, Sweeney P, Kuchnir FT, Sutton HS, Chodak GW, Farah
`R, Weichselbaum RR. Photon neutron mixed beam radiotherapy of locally
`advanced prostate cancer: results at the University of Chicago, Int J Radiat Oncol
`Biol Phys 33:3-14, 1995.
`
`
`
`
`
`
`
`
`117. Chodak GW. Prostate Cancer-How to Outsmart the #2 Cancer Killer of Men.
`Health Confidential 5-6, January 1995.
`
`118. Gerber GW, Chodak GW, Rukstalis DB. Combined Laparoscopic and
`Transurethral Neodymium: Yttrium-Aluminum-Garnet Laser Treatment of
`Invasive Bladder Cancer. Urology 44(2):230-233, February, 1995.
`
`119. Calciano R, Chodak GW, Garnick MB, Kuban DA, Resnick MI. The
`prostate cancer conundrum. Patient Care 29(7): 84-104, April 1995.
`
`120. Sarosdy MF, White D, Soloway MS, Sheinfeld J, Hudson MA,
`Schellhammer PF, Jarowenko MV, Adams G, Blumenstein BA, Chodak G.
`Results of a multicenter trial using the bladder tumor antigen test to monitor for
`and diagnose recurrent bladder cancer. J Urology, 154:1-6, August 1995.
`
`121. Soloway MS, Sharifi R, Wajsman Z, McLeon D, Wood DP, Jr., Puras-Baez
`A for the Lupron Depot Neoadjuvant Prostate Cancer Study Group. Randomized
`prospective study comparing radical prostatectomy alone versus radical
`prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxMO)
`prostate cancer. J Urol, 154:424-428, August 1995.
`
`122. Chodak GW. The stock article reviewed. Oncology Vol.9 (9): 816,
`September, 1995.
`
`123. Jarrard DF, Chodak GW. Prostate cancer staging after radiation utilizing
`laparoscopic pelvic lymphadenectomy. Urology 46(4): 538-541, October 1995.
`
`124. Bales GT, Williams MJ, Sinner M, Thisted RA, Chodak GW. Short-term
`outcomes after cryosurgical ablation of the prostate in men with recurrent prostate
`carcinoma following radiation therapy. Urology 46(5): 676-680, November 1995.
`
`125. Soloway MS, Schellhammer PF, Smith JA, Jr., Chodak GW, Vogelzang NJ,
`Kennealey GT. Bicalutamide in the treatment of advanced prostate carcinoma: a
`
`
`
`
`
`
`
`phase II noncomparative multicenter trial evaluating safety, efficacy and long-term
`endocrine effects of monotherapy. Jr of Urology 154:2110-2114, December 1995.
`
`126. Chodak GW. Editorial: what to expect from prostate cancer.
` J Urol 154:2131-2133, December 1995.
`
`127. Chodak GW, Sharifi R, Kasimis B, Block NL, Macramalla E, Kennealy GT.
`Single-agent therapy with bicalutamide: a comparison with medical or surgical
`castration in the treatment of advanced prostate carcinoma. Urology 46(6): 849-
`855, December 1995.
`
`128. Kim JH, Tanabe T. Chodak GW, Rukstalis DB. In vitro anti-invasive effects
`of N-(4-Hydroxyphenyl) -retinamide on Human Prostatic Adenocarcinoma.
`Anticancer Research 15: 1429-1434, 1995.
`
`
`129. Soloway MS, Schellhammer PF, Smith JA, Chodak GW, Kennealey GT.
`Bicalutamide in th treatment of advanced prostatic carcinoma: a phase II
`multicenter trial. Urology 47(Supplement 1A): 33-37, January 1996.
`
`130. Bales GT, Chodak GW. A controlled trial of bicalutamide versus castration
`in patients with advanced prostate cancer. Urology 47(Supplement 1A): 38-43,
`January, 1996.
`
`131. Palmer JS, Worwag EM, Conrad WG, Blitz B, Chodak GW. Same day
`surgery for radical retropubic prostatectomy: is it an attainable goal? Urology
`47(1): 23-28, January 1996.
`
`132. Gerber GS, Bales GT, Gornik HL, Haraf KJ, Chodak GW, Rukstalis DB.
`Treatment of prostate cancer using external beam radiotherapy after laparoscopic
`pelvic lymph node dissection. British J of Urology 77:870-875, January 1996.
`
`133. Igawa M, Urakami S, Shiina H, Ishibe T, Shirane T, Usui T, Chodak GW.
`Immunohistochemical evaluation of proliferation cell nuclear antigen, prostate-
`specific antigen and alpha 1-antichymotrypsin in human prostate cancer. Br J Urol
`77(1): 107-12, January 1996.
`
`
`
`
`
`
`
`
`134. Chodak GW. Additional therapy after prostatectomy: implications for patient
`counseling (editorials). J of Natl Cancer Institute 88(3/4):139-140, February 1996.
`
`135. Chodak GW. Questions From Readers, Oncology Rounds. Oncology News
`International 5(4): 42, April 1996.
`
`136. Chodak GW, Thisted RA. Re: Long-term survival and mortality in prostate
`cancer treated with non-curative intent. J Urol 155(6): 2039-41, June 1996.
`
`137. Soloway MS, Briggman V, Carpinito GA, Chodak GW, Church PA, Lamm
`DL, Lange P, Messing E, Pasciak RM, Reservitz GB, Rukstalis DB, Sarosdy MF,
`Stadler WM, Theil RP, Hayden CL. Use of a new tumor marker, urinary NMP22,
`in the detection of occult or rapidly recurring transitional cell carcinoma of the
`urinary tract following surgical treatment. J Urol 156(2): 363-7, August 1996.
`
`138. Gerber GS, Thisted RA, Scardino PT, Frohmuller HGW, Schroeder FH,
`Paulson DF, Middleton AW, Rukstalis DB, Smith JA, Schellhammer PF, Ohori M,
`Chodak GW. Results of Radical Prostatectomy in Men with Clinically Localized
`Prostate Cancer - Multi - Intistutional Pooled Analysis. JAMA 276 (8): 615-619,
`August 1996.
`
`139. Carpinito GA, Stadler WM, Briggman JV, Chodak GW, Church PA, Lamm
`DL, Lange PH, Messing EM, Pasciak RM, Reservitz GB, Ross RN, Rukstalis DB,
`Sarosdy MF, Soloway MS, Theil RP, Vogelzang N, Hayden CL. Urinary nuclear
`matix protein as a marker for transitional cell carcinoma of the urinary tract. J
`Urol 156(4): 1280-5, October 1996.
`
`140. Palmer JS, Chodak GW. Defining the role of surveillance in the management
`of localized prostate cancer. Urol Clin North Am 23(4): 551-556, November,
`1996.
`
`141. Igawa M, Urakami S, Shiina H, Ishibe T, Usui T, Chodak GW. Association
`of nm23 protein levels in human prostates with proliferation cell nuclear antigen
`expression at autopsy. Eur Urol 30(3): 383-387, 1996.
`
`
`
`
`
`
`
`
`142. Chodak GW. Multidisciplinary Rounds, Early-Stage Prostate Cancer
`Treatment Options. Cancer Practice 5(1): 14, January/February 1997.
`
`143. Chodak GW. Prostate queries. Questions and uncertainties about prostate
`cancer. The Lancet 349:580, February 22, 1997.
`
`144. Chodak GW. Carcinoma of the prostate. Lancet 350:9077, 592, August
`1997.
`
`145. Sarosdy MF, Hudson MA, Ellis WJ, Soloway MS, de Vere White R,
`Sheinfeld J, Jarowenko MV, Schellhammer PF, Schervish EW, Patel JV, Chodak
`GW, Lamm DL, Johnson RD, Henderson M, Adams G, Blumenstein BA, Thoelke
`KR, Pfalzgraf RD, Murchison HA, Brunelle SL. Improved detection of recurrent
`bladder cancer using the Bard BTA stat Test. Urology 50(3): 349-53, September
`1997.
`
`146. Chodak GW. Bicalutamide-associated fulminant hepatic failure. Urology
`50(6): 1027, December 1997.
`
`147. Gerber GS, Gornik HL, Goldfischer ER, Chodak GW, Rukstalis DB.
`Evaluation of changes in prostate specific antigen in clinically localized prostate
`cancer managed without initial therapy. J Urol 159(4): 1243-1246, April 1998.
`
`148. Gerber GS, Zagaja GP, Bales GT, Chodak GW, Contreras BA. Saw palmetto
`(Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic
`parameters and voiding symptoms. Urology 51(6): 1003-1007, June 1998.
`
`149. Worwag E, Chodak GW. Overnight hospitalization after radical
`prostatectomy: the impact of two clinical pathways on patient satisfaction, length
`of hospitalization, and morbidity. Anesth Analg 87(1): 62-67, July 1998.
`
`150. Sarosdy MF, Schellhammer PF, Sharifi R, Block NL, Soloway MS, Venner
`PM, Patterson AL, Vogelzang NJ, Chodak GW, Klein EA, Schellenger JJ,
`
`
`
`
`
`
`
`Kolvenbag GJ. Comparison of goserelin and leuprolide in combined androgen
`blockade therapy. Urology 52(1): 82-88, July 1998.
`
`151. Chodak GW. Comparing treatments for localized prostate cancer-persisting
`uncertainty. JAMA 280(11): 1008-10, September 16, 1998.
`
`152. Myers,RE, Chodak,GW, Wolf,TA, Burgh,DY, McGrory,GT, Marcus,SM,
`Diehl,JA, Williams,M. Adherence by African American Men to Prostate Cancer
`Education and Early Detection. Cancer, July 1, 1999 Volume 86 number 1; 88-
`104.
`
`153. Kirsh,EJ, Worwag,EM, Sinner,M, Chodak, GW. Using Outcome Data and
`Patient Satisfaction Surveys To Develop Policies Regarding Minimum Length Of
`Hospitalization After Radical Prostatectomy. UROLOGY 56(1): 101-107, July
`2000.
`
`154. Chodak, GW, Kolvenbag,GJCM. Will the Experience with Tamoxifen in
`Breast Cancer Help Define the Role of Antiandrogens in Prostate Cancer? Prostate
`Cancer and Prostatic Diseases 4: 72-80. 2001.
`
`155. KapsE, MoenckJ, ChodakGW. The Origin of Support Groups for Prostate
`Cancer Survivors and Their Families. Family Urology, Vol VI, Issue 4, 2001
`
`156. Chodak,GW, Keane,T, Klotz,L, and the Hormone Therapy Study Group.
`Critical Evaluation of Hormonal Therapy for Carcinoma of the Prostate.
`UROLOGY 60: 201-208, 2002.
`
`157. Wilkinson,S, Gomella,L, Smith,J, Brawer,M, Dawson,N, Wajsman,Z, Dai,L,
`Chodak,GW. Attitudes and Use of Complementary Medicine in Men with Prostate
`Cancer. The Journal of Urology, 2505-2509, December 2002.
`
`158. Wilkinson,S, Chodak,G. Critical Review of Complementary Therapies for
`Prostate Cancer. Journal of Clinical Oncology, 2199-2210 Vol 21 no. 11 June 1,
`2003.
`
`
`
`
`
`
`
`
`
`
`159. Wilkinson,S, List,M, Sinner,M, Dai,L, Chodak,GW. Educating African-
`American Men about Prostate Cancer: Impact on Awareness and Knowledge.
`Urology 61: 308-313, 2003.
`
`160. Wilkinson Simon; Warren Katherine; Ramsden Alistair; Matthews Alicia;
`Chodak Gerald, Do "rapid" PSA assays reduce anxiety and stress of prostate
`cancer patients undergoing regular review? A prospective evaluation.
`Urology 2008; 71(4): 567-72.
`
`161. Warren Katherine S; Osborn Jonathan; Chodak Gerald W
`Assessment of American urologists' approach to hormonal management of prostate
`cancer. Urology 2006; 68(6): 1305-7.
`
` PUBLISHED ABSTRACTS:
`
`1. Chodak GW. The economic ramifications of using prophylactic antibiotics in
`urology. Presented at American Urological Association, May 1980.
`
`2. Chodak GW, Haudenschild C, Gittes RF and Folkman J. Angiogenesis as a
`marker of neoplastic and pre-neoplastic lesions of the human bladder. Presented at
`American Urological Association, May 1980.
`
`3. Chodak GW, Summerhayes I and Folkman J. Angiogenesis assay of benign
`and malignant mammalian urothelium. Presented at American College of
`Surgeons, October 1980.
`
`4. Chodak GW, Margoles D and Craven JM. Treatment of experimental bladder
`cancer by protamine sulfate. Presented at American Urological Association
`Meeting, April 1983.
`
`5. Chodak GW, Neumann J, Decath R an
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
